Suppr超能文献

肝脏X受体调节剂:对脂质代谢的影响及在动脉粥样硬化治疗中的潜在用途。

Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.

作者信息

Fiévet C, Staels B

机构信息

Institut Pasteur de Lille, Lille, F-59019, France.

出版信息

Biochem Pharmacol. 2009 Apr 15;77(8):1316-27. doi: 10.1016/j.bcp.2008.11.026. Epub 2008 Dec 3.

Abstract

Liver X receptors (LXRs) are nuclear receptors that play a crucial role in regulating the expression of genes involved in lipid metabolism. Ligand activation of LXRs improves cholesterol homeostasis via multiple coordinated effects, and this function is likely to explain in part the protective effects of LXR activation on atherosclerosis reported in animal models. However, LXR activation may also induce undesirable side effects, such as lipogenesis and hypertriglyceridemia. This review discusses the potential to develop LXR modulators as therapeutic agents for atherosclerosis.

摘要

肝脏X受体(LXRs)是核受体,在调节参与脂质代谢的基因表达中起关键作用。LXRs的配体激活通过多种协同作用改善胆固醇稳态,这一功能可能部分解释了在动物模型中报道的LXR激活对动脉粥样硬化的保护作用。然而,LXR激活也可能诱发不良副作用,如脂肪生成和高甘油三酯血症。本文综述了开发LXR调节剂作为动脉粥样硬化治疗药物的潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验